Announce Date | 01/16/2025 |
EPS Normalized Actual | $2.22 (Beat by $0.6) |
EPS GAAP Actual | $2.22 (Beat by $0.6) |
Revenue Actual | $16.108B |
Revenue Surprise | Beat by $16108M |
Announce Date | 12/31/1969 (Pre-Market) |
EPS Normalized Estimate | $ |
EPS GAAP Estimate | $ |
Revenue Estimate | $0B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2028 | 10.67839 | 9.98 | 10.09883 | 11.41254 | 5 |
Dec 2027 | 8.70843 | 12.24 | 8.3766 | 8.92839 | 4 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ4 2024 (Dec 2024) | 2.25 | 2.25 | 16.108B | 25.31% | 16108M |
FQ3 2024 (Sep 2024) | 1.91 | 1.91 | 15.304B | 18.86% | 15304M |
FQ2 2024 (Jun 2024) | 1.93 | 1.93 | 15.019B | 16.23% | 15019M |
FQ1 2024 (Mar 2024) | 2.13 | 2.13 | 26.27B | 48.09% | 26270M |
FQ4 2023 (Dec 2023) | 0.86 | 0.86 | 12.031B | 1.11% | 12031M |
FQ3 2023 (Sep 2023) | 1.39 | 1.39 | 12.418B | 2.25% | 12418M |
FQ2 2023 (Jun 2023) | 1.25 | 1.25 | 12.582B | 2.61% | 12582M |
FQ1 2023 (Mar 2023) | 1.72 | 1.72 | 13.636B | 100% | 13636M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 2.6835 | -- | 2.59835 | 2.77947 | 4 |
FQ3 2027 (Sep 2027) | 2.4939 | -- | 2.41476 | 2.58309 | 3 |
FQ2 2027 (Jun 2027) | 2.5112 | -- | 2.43151 | 2.60101 | 4 |
FQ1 2027 (Mar 2027) | 2.6123 | -- | 2.52941 | 2.70572 | 3 |
FQ4 2026 (Oct 2026) | 2.14461 | -- | 2.05564 | 2.21618 | 7 |
FQ3 2026 (Jul 2026) | 2.13187 | -- | 2.04343 | 2.20301 | 4 |
FQ2 2026 (Jun 2026) | 2.20789 | -- | 2.10796 | 2.30109 | 4 |
FQ1 2026 (Mar 2026) | 2.27183 | -- | 2.16901 | 2.36773 | 3 |
FQ4 2025 (Dec 2025) | 1.81925 | -23.68 | 1.75793 | 1.89026 | 9 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 16.71B | -- | 16.31B | 17.17B | 3 |
FQ3 2027 (Sep 2027) | 16.41B | -- | 16.01B | 16.86B | 3 |
FQ2 2027 (Jun 2027) | 16.12B | -- | 15.72B | 16.56B | 3 |
FQ1 2027 (Mar 2027) | 15.82B | -- | 15.44B | 16.26B | 3 |
FQ4 2026 (Oct 2026) | 16.35B | -- | 15.82B | 16.77B | 5 |
FQ3 2026 (Jul 2026) | 16.29B | -- | 15.77B | 16.71B | 5 |
FQ2 2026 (Jun 2026) | 17.1B | -- | 16.5B | 17.65B | 3 |
FQ1 2026 (Mar 2026) | 17.18B | -- | 16.58B | 17.74B | 3 |
FQ4 2025 (Dec 2025) | 15.51B | -3.83 | 15.11B | 15.98B | 8 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | 2.25 | 2.25 | 100% | |
FQ3 2024 (Sep 2024) | 1.91 | 1.91 | 100% | |
FQ2 2024 (Jun 2024) | 1.93 | 1.93 | 100% | |
FQ1 2024 (Mar 2024) | 2.13 | 2.13 | 100% | |
FQ4 2023 (Dec 2023) | 0.86 | 0.86 | 100% | |
FQ3 2023 (Sep 2023) | 1.39 | 1.39 | 100% | |
FQ2 2023 (Jun 2023) | 1.25 | 1.25 | 100% | |
FQ1 2023 (Mar 2023) | 1.72 | 1.72 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | $0B | $16.11B | $16108M | 100% |
FQ3 2024 (Sep 2024) | $0B | $15.3B | $15304M | 100% |
FQ2 2024 (Jun 2024) | $0B | $15.02B | $15019M | 100% |
FQ1 2024 (Mar 2024) | $0B | $26.27B | $26270M | 100% |
FQ4 2023 (Dec 2023) | $0B | $12.03B | $12031M | 100% |
FQ3 2023 (Sep 2023) | $0B | $12.42B | $12418M | 100% |
FQ2 2023 (Jun 2023) | $0B | $12.58B | $12582M | 100% |
FQ1 2023 (Mar 2023) | $0B | $13.64B | $13636M | 100% |